AEGON Asset Management (UK)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97.2M Buy
81,026
+17,035
+27% +$17.4M 1.04% 23
2026
Q1
$58.9M Sell
63,991
-3,338
-5% -$3.38M 0.78% 30
2025
Q4
$72.4M Buy
67,329
+17,475
+35% +$16.7M 0.86% 24
2025
Q3
$38M Sell
49,854
-18,915
-28% -$14.1M 0.45% 60
2025
Q2
$53.6M Sell
68,769
-2,475
-3% -$1.92M 0.69% 42
2025
Q1
$58.8M Sell
71,244
-4,097
-5% -$3.41M 0.86% 31
2024
Q4
$58.2M Sell
75,341
-2,845
-4% -$2.36M 0.77% 30
2024
Q3
$69.2M Buy
78,186
+709
+0.9% +$637K 0.94% 24
2024
Q2
$70.2M Buy
77,477
+15,571
+25% +$12.5M 0.99% 21
2024
Q1
$48.1M Buy
61,906
+54,111
+694% +$38.5M 0.72% 40
2023
Q4
$4.55M Buy
+7,795
New +$4.55M 0.07% 104

Other funds holding LLY

AEGON Asset Management (UK)'s LLY Position: Q2 2026 in Review

AEGON Asset Management (UK) increased its Eli Lilly (LLY) stake by 27% in Q2 2026, buying an estimated $17.4M and bringing the position to 81,026 shares worth $97.2M. The position accounts for 1.04% of the portfolio, ranked #23.

AEGON Asset Management (UK) first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • AEGON Asset Management (UK) held 81,026 shares of Eli Lilly worth $97.2M as of Q2 2026.
  • AEGON Asset Management (UK) bought 17,035 Eli Lilly shares in Q2 2026, an estimated $17.4M.
  • Eli Lilly made up 1.04% of AEGON Asset Management (UK)'s portfolio in Q2 2026, its #23 holding.
  • AEGON Asset Management (UK) first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on AEGON Asset Management (UK)'s 13F filing for Q2 2026, filed 13 Jul 2026.